Skip to main content
Caplight Logo









Swan NeuroTech

Swan NeuroTech

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://swanneuro.com/

Last Round

Grant

May 28, 2024

Total Funding Raised

$20,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Swan NeuroTech operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Grant round in May 2024.

Swan NeuroTech is a biotechnology company that develops biodegradable, biomaterial-based drug delivery implants designed to facilitate peripheral nerve repair and regeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Swan NeuroTech Comparables

Compare Swan NeuroTech with similar companies based on industry and business-model similarity.

Swan NeuroTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Renerva, Inc.
90%
BioCircuit Technologies
87%
Neuraptive Therapeutics
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Swan NeuroTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 28, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 148% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Swan NeuroTech Filings

Explore SEC and related filing metadata, where available.

Swan NeuroTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Swan NeuroTech's valuation, stock price, and market status.

Is Swan NeuroTech a public or private company?

Swan NeuroTech is a private company.

What is the current stock price of Swan NeuroTech?

Swan NeuroTech is a private company, so its shares have no public market price. Caplight tracks Swan NeuroTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Swan NeuroTech worth (valuation)?

Valuation information for Swan NeuroTech is not publicly available.

Can I buy Swan NeuroTech stock?

Swan NeuroTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Swan NeuroTech's last funding round?

Swan NeuroTech's most recent funding round was Grant on May 28, 2024.

Who are the main investors in Swan NeuroTech?

Investor information for Swan NeuroTech is not publicly disclosed.

Will Swan NeuroTech IPO soon?

No public IPO plans have been announced for Swan NeuroTech.

How can I track Swan NeuroTech secondary market activity?

Caplight tracks bids, offers, and trades in Swan NeuroTech's shares on secondary markets.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range1
Year Founded2019
Last FundingMay 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?